Funder
BioMarin Pharmaceutical INC
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference44 articles.
1. Merker A, Neumeyer L, Hertel NT, Grigelioniene G, Mohnike K, Hagenäs L. Development of body proportions in achondroplasia: Sitting height, leg length, arm span, and foot length. Am J Med Genet A. 2018;176(9):1819–29.
2. Vajo Z, Francomano CA, Wilkin DJ. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, muenke craniosynostosis, and crouzon syndrome with acanthosis nigricans. Endocr Rev. 2000;21(1):23–39.
3. Wright MJ, Irving MD. Clinical management of achondroplasia. Arch Dis Child. 2012;97(2):129–34.
4. Foldynova-Trantirkova S, Wilcox WR, Krejci P. Sixteen years and counting: The current understanding of fibroblast growth factor receptor 3 (fgfr3) signaling in skeletal dysplasias. Hum Mutat. 2011;33(1):29–41.
5. Horton WA, Hall JG, Hecht JT. Achondroplasia Lancet. 2007;370(9582):162–72.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献